T-cell/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: Report on 61 patients and review of literature

Leukemia and Lymphoma

Volumn 48, Issue 9, 2007, Pages 1764-1773

  El Weshi, Amr ^a   Akhtar, Saad ^a   Mourad, Walid A ^a   Ajarim, Dahish ^a   Abdelsalm, Mahmoud ^a   Khafaga, Yasser ^a   Bazarbashi, Shouki ^a   Maghfoor, Irfan ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Chemotherapy; Nodular lymphocyte predominant Hodgkin lymphoma; Prognosis; T cell histiocyte rich B cell lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; PREDNISONE; RITUXIMAB; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CLINICAL FEATURE; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG FATALITY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HISTIOCYTE-RICH B CELL LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SPLEEN DISEASE; SURVIVAL RATE; T LYMPHOCYTE-RICH B CELL LYMPHOMA; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; PROGNOSIS; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 34548583485     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701559124     Document Type: Article

References (31)

1. Greer, J. P., Macon, W. R., Lamar, R. E., Wolff, S. N., Stein, R. S. and Flexner, J. M. (1995) T-cell-rich large B-cell lymphomas: Diagnosis and response to therapy of 44 patients. J Clin Oncol, 13, pp. 1742-1750.
2. Bouabdallah, R., Mounier, N., Guettier, C., Molina, T., Ribrag, V. and Thieblemont, C. (2003) T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: A matched-control analysis. J Clin Oncol, 21, pp. 1271-1277.
3. Sehn, L. H., Donaldson, J., Chhanabhai, M., Fitzgerald, C., Gill, K. and Klasa, R. (2005) Introduction of combined CHOP plus Rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol, 23, pp. 5027-5033.
4. Ramsay, A. D., Smith, W. J. and Isaacson, P. G. (1988) T-cell rich B-cell lymphoma. Am J Surg Pathol, 12, pp. 433-443.
5. Ng, C. S., Chan, J KC, Hui, P. K. and Lau, W. H. (1989) Large B-cell lymphoma with a high content of reactive T cells. Hum Pathol, 20, pp. 1145-1154.
6. Osborne, B. M., Butler, J. J. and Pugh, W. C. (1990) The value of immunophenotyping on paraffin sections in the identification of T-cell-rich B-cell large cell lymphomas: Lineage confirmed by JH rearrangement. Am J Surg Pathol, 14, pp. 933-938.
7. Chittal, S. M., Brousset, P., Voigt, J. J. and Delsol, G. (1991) Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology, 19, pp. 211-220.
8. Macon, W. R., Williams, M. E., Greer, J. P., Stein, R. S., Collins, R. D. and Cousar, J. B. (1992) T-cell rich B-cell lymphomas: A clinicopathologic study of 19 cases. Am J Surg Pathol, 16, pp. 351-363.
9. Delabie, J., Vandenberghe, E., Kennes, C., Verhoef, G., Foschini, M. P. and Stul, M. (1992) Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease. paragranuloma subtype. Am J Surg Pathol, 16, pp. 37-48.
10. Lim, M., Beaty, M., Sorbara, L., Cheng, R. Z., Pittaluga, S. and Raffeld, M. (2002) T-cell/histiocyte-rich large B-cell lymphoma. A heterogeneous entity with derivation from germinal B cells. Am J Surg Pathol, 26, pp. 1458-1466.
11. Boudova, L., Torlakovic, E., Delabie, J., Reimer, P., Pfistner, B. and Wiedenmann, S. (2003) Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte-rich B cell lymphoma. Blood, 102, pp. 3753-3758.
12. Baddoura, F. K., Chan, W. C., Masih, A. S., Mitchell, D., Sun, N. C. and Weisenburger, D. D. (1995) T-cell-rich large B-cell lymphoma. A clinicopathologic study of eight cases. Am J Clin Pathol, 103, pp. 65-75.
13. Schmidt, U., Metz, K. A. and Leder, L. D. (1995) T-cell-rich large B-cell lymphoma and lympocyte predominant Hodgkin's disease: Two closely related entities. Br J Haematol, 90, pp. 398-403.
14. Rudiger, T., Ott, G., Ott, M. M., Müller-Deubert, S. M. and Müller-Hermelink, H. K. (1998) Differential diagnosis between classic Hodgkin disease, T-cell rich B-cell lymphoma and paragranuloma by paraffin immunohistochemistry. Am J Surg Pathol, 22, pp. 1184-1191.
15. Rodriguez, J., Pugh, W. C. and Cabnillas, F. (1993) T-cell-rich B cell Lymphoma. Blood, 82, pp. 1586-1589.
16. Krishnan, J., Wallberg, K. and Frizzera, G. (1994) T-cell-rich large B-cell lymphoma. A study of 30 cases supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol, 18, pp. 211-220.
17. Achten, R., Verhoef, G., Vanuytsel, L. and De Wolf-Peeters, C. (2002) T-cell/histocyte-rich large B-cell lymphoma: A distinct clinicopathologic entity. J Clin Oncol, 20, pp. 1269-1277.
18. Ripp, J. A., Louie, D. C., Chan, W., Nawaz, H. and Portlock, C. S. (2002) T-cell rich B-cell lymphoma: Clinical distinctiveness and response to treatment in 45 patients. Leuk Lymphoma, 43, pp. 1573-1580.
19. Aki, H., Tuzuner, N., Ongoren, S., Baslar, Z., Soysal, T. and Ferhanoglu, B. (2004) T-cell-rich B-cell lymphoma: A clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma. Leuk Res, 28, pp. 229-236.
20. Abramson, J. S. (2006) T-cell/histiocyte-rich B-cell lymphoma: Biology, diagnosis and management. The Oncologist, 11, pp. 384-392.
21. Fraga, M., Garcia-Riviero, A., Sanchez-Verde, L., García-Rivero, A. and Piris, M. A. (2002) T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: Differential diagnosis from Hodgkin's lymphoma. Histopathol, 41, pp. 216-229.
22. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med, 329, pp. 987-994.
23. Gatter, K. C. and Warnke, R. A. (2001) Diffuse large B cell lymphoma. Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues, pp. 171-174. IARC Press, Lyon
24. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K. and Cleary, M. L. (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, pp. 1361-1392.
25. Rudiger, T., Jaffe, E. S., Delsol, G., deWolf-Peeters, C., Gascoyne, R. D. and Georgii, A. (1998) Workshop on Hodgkin's disease and related disease (grey zone lymphoma). Ann Oncol, 9, pp. 31-38.
26. Rudiger, T., Gascoyne, R. D., Jaffe, E. S., de Jong, D., Delabie, J. and De Wolf-Peeters, C. (2002) Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol, 13, pp. 44-51.
27. McBride, J. A., Rodriguez, J., Luthra, R., Ordóñez, N. G., Cabanillas, F. and Pugh, W. C. (1996) T-cell-rich B large cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am J Surg Pathol, 20, pp. 193-201.
28. Armitage, J. O. and Weisenburger, D. D. (1998) New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. J Clin Oncol, 16, pp. 2780-2795.
29. Skinnider, B. F., Connors, J. M. and Gascoyne, R. D. (1997) Bone marrow involvement in T-cell-rich B-cell lymphoma. Am J Clin Pathol, 108, pp. 489-491.
30. Coiffier, B. (2005) State-of-the-art therapeutics: Diffuse large B-cell lymphoma. J Clin Oncol, 23, pp. 6387-6393.
31. Pfreundschuh, M., Trumper, L., Osterborg, A., Pettengell, R., Trneny, M. and Imrie, K. (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good prognosis diffuse large B-cell lymphoma: A randomized controlled trial by the MabThera International Trial (MinT) Group. Lancet Oncol, 7, pp. 379-391.